about two weeks ago, a former emory university professor pled guilty to falsifying his tax returns to conceal his work for the chinese government. the professor worked simultaneously and secretly for six years for emory university and overseas for chinese universities affiliated with the communist party of china, conducting similar research projects at both institutions. despite this clear conflict of interest he failed to report any of his at least $500,000 in foreign income on his federal tax returns. that very same day, a professor at university of arkansas was arrested on charges of wire fraud for allegedly failing to disclose his ties to the chinese government despite being required to do so as a grant recipient of money from nasa. nasa. and just this past week we found out this problem reached my home state of ohio when the department of justice announced arrest of a researcher with the renowned cleveland clinic receiving 3.6 million in taxpayer funded grants from the national institutes of health, again, taxpayer dollars, to secure that grant, he's accused of lying to hide the

at emory university hospital in atlanta, researchers believe they discovered the achilles heel of the virus. it's there on top of the notorious red hook we've seen. >> what this means is this is now an important target for development of much-needed vaccine. >> reporter: and there is more encouraging news from the emory discovery. using blood plasma from recovered patients, they should be able to inject those into people that are sick carl donated blood after taking 29 days to recover from covid-19. >> and they're speculating that because i spent so long with the virus that i built up so many antibodies, it's off the charts. >> reporter: the question researchers are asking, if you've recovered from covid, how long will you have antibodies to offer protection >> will they still be there, let's say, in the fall or next winter if we get another wave of, you know, the sars covi 2 infection? will they still be around and be able to provide protection. >> reporter: and we don't know that right now? >> we do not know that right now, no. >> reporter: if the antibodies that provide immunity, p

. ♪ narrator: near naha, capital of okinawa, in the american advance on the emory -- the enemy, a marinevehicle is overturned and lies burning with four of her crew trapped inside. one group member thrown clear by the explosion, staggering with shock, comes in as marines fight to rescue the four men inside. but the flames reached the ammunition. and all hope of rescue is gone. in the same sector, flame-throwing tanks attack japanese soldiers' ammunition. [explosions] destruction is total. these actions accompanied the 10th army's bitter fight for the southern tip of okinawa. one after another, japanese positions are burned down. the japanese have already conceded the tactical loss of okinawa. a costly but indispensable gain in the war against japan. ♪ >> you are watching american history tv, all weekend, every weekend on c-span three. announcer: to mark patriots' day, a massachusetts state holiday commemorating the battles of lexington, concord, and menotomy in april of 1775, monticello hosts a conversation with president thomas jefferson, portrayed by bill barker. he recounts the events

. >> 57 year old phil clark looked forward to his followup visit at emory university hospital. >> st always a great day to feel healthy after what i went through. >> just three weeks ago he was discharged after a battle against covid-19. >> i started wondering how bad is this going to be. am i close to dying? >> clark took part in a grounds-breaking global trial with early result thabs showed remdesivir reduced average hospitalizations from 15 to 11 day days. dr. aneesh mehta was the lead investigator at emory university. >> i think remdesivir is onetot. >> in the next phase of the trial dr. mehta and colleaguings are combining remdesivir to stop the virus from multiplying with a powerful anti-inflammatory drug, baricitinib, a so called immune modulator that aims to prevent organ damage by calming down an inflamed immune system. >> the remdesivir stops the virus from replicating inside the cell, and the immune modulator puts out the fire. >> at, what the remdesivir does is stop the spark. and the immune modulator will hopefully be putting dirt on the fire. >> a one two punch. >> a on

>>new research from emory shows that nearly all patients treated for covid-19 developed virus neutralizing antibodies those that bind the virus cells to block infections antibodies are key to our understanding of what will be needed for protection against covid-19 researchers say there are more than a 170 antibody tests against covid-19 and they all entered the virus target. >>normally stars kobe to the virus that causes covid-19 disease interacts with the receptor called ace too. we just found in the service of most cells within the long. >>and what is our producer spire body in massive quantities. and these antibodies can stick around for a long period of time off to the infection is your songs, researchers focused on how antibodies respond specifically on the spike part of the virus. neutralizing antibody responses or neutralizing antibodies per se block this key. >>or the spike protein on this on the virus and prevent the virus from ever entering a cell and starting an infection every researchers say patients who are hospitalized for covid-19. >>developed antibodies within 6 days of te

here to talk that through is the lead investigator at emory university for this remdesivir trial. he's also an associate professor of infectious diseases. doctor, first, can you take us through what the clinical trial was? what did you guys do and try to test? >> thank you, chris. i appreciate the opportunity to talk about the trial that we have been working on. this is called the nih adaptive covid-19 trial of therapeutics. or act trial as we like to call it. there were no good medications available to treat covid-19 and so the scientific leaders at the nih looked through a catalog of potential medications and found that remdesivir, which had been tested for ebola seemed to have very good activity against coronaviruses so they put together this large international study in adaptive clinical trial model to examine whether remdesivir seemed to -- would help patients with covid-19. we were fortunate at emory to be one of the initial sites, along with our colleagues in the network, and we were able to initiate the study in very early of march. we very quickly enrolled, much more quic

james curran, dean of emory university school of public health, co-director of the emory center for research. thanks for making time and thanks for your service. >> thank you, rachel. >> we've got much more ahead this friday night. do stay with us. y with us. because our way works great for us! but not for your clients. that's why we're a fiduciary, obligated to put clients first. so, what do you provide? cookie cutter portfolios? nope. we tailor portfolios to our client's needs. but you do sell investments that earn you high commissions, right? we don't have those. so, what's in it for you? our fees are structured so we do better when our clients do better. at fisher investments we're clearly different. confident financial plans, calming financial plans, complete financial plans. they're all possible with a cfp® professional. find yours at letsmakeaplan.org. they're all possible with a cfp® professional. we're finally back out in our yard, but so are they. scotts turf builder triple action. it kills weeds, prevents crabgrass and feeds so grass can thrive, guaranteed. our backyard is back. t

let me ask you, you are working on a vaccine trial at emory.rd some optimistic news from you know scientists at oxford university have been studying this. can you update us on your efforts and how quickly or promising your trial for a vaccine is right now? >> well, first of all, there are over 70 vaccines in pre-clinical or clinical trials. dr. fauci said when he well talked about vaccines we need lot of shots on goes and we need a lot of hose shots to become goals. in other words, we are not look for one vaccine to work. we are looking for multiple vaccines to work. the vaccine we are involved with is a novel type of vaccine. it's an mrna vaccine, a vaccine that ensures part of night the human body and starts an immune reaction, an immune response as a result of that we are just in the phase 1. the phase 1 is just a safety and introducing of the drug and the vaccine. and the naid just approved to expand this study for older populations. so once we have completed enrollment, that's enrolled here just at emory and at kaiser in washington state.

she's an assistant professor at emory university's school of medicine. thank you so much for joining us. >> thank you for having me. >> so the chicago area medical examiner is looking into a possible coronavirus link to deaths as far back as november. of course, we've heard about the case in france possibly going back to december. why is it so critical to find out if this virus was circulating late last year? and how much does that change anything that we're dealing with right now? >> so i think that it doesn't change a lot that we're doing clinically. not how we would handle anything currently. i think where it would be interesting to know how far back it was here is that it will last look at our systems for early warning signs, ways of doing what we call syndromic surveillance where we can look at medical records and see if we're seeing an unusual uptick in something. if we do see that going back to, say, december when we compare to prior years, that may help us in the future to build better warning systems so that if there is an uptick in something th

trial at emory university. >> i think remdesivir is one important tool.also need to look for other ways to help our patients. >> reporter: in the next phase of the trial, dr. mehta and colleagues are combining remdesivir, to stop the virus from multiplying, with a powerful anti-inflammatory drug, baricitinib, a so-called immune modulator that aims to prevent organ damage by calming down an inflamed immune system. >> the remdesivir stops the virus from replicating inside the cell, and the immune modulator puts out the fire. >> what the remdesivir does is stop the spark, and the immune modulator will hopefully be putting dirt on the fire to put it out. >> reporter: a one-two punch. >> a one-two punch. >> reporter: dr. mehta's team is looking at whether this powerful combination could make recovery even faster, and possibly reduce the mortality rate in a way remdesivir alone has not yet been shown to do. >> a drug can block this virus. >> reporter: when dr. anthony fauci, the government's top infectious disease expert, announced remdesivir was the first drug

well as the race for coronavirus vaccine escalates emory university researchers say they've made some significant progress in the fight against covid-19 researchers have created a new test to study hospitalized patients to find out just how quickly they developed antibodies to fight the infection. >>our chief session and re has more on that. >>new research from emory shows that nearly all patients treated for covid-19 developed virus neutralizing antibodies those that bind the virus cells to block infections antibodies are key to our understanding of what will be needed for protection against covid-19 researchers say there are more than a 170 antibody tests against covid-19 and they all entered the virus target. >>normally stars kobe to the virus that causes covid-19 disease interacts with the receptor called ace too. we just found in the service of most cells within the long. >>and what is our producer spire body in massive quantities. and these antibodies can stick around for a long period of time off to the infection is your songs, researchers focused on how antibodies respond spec

it's a race for coronavirus vaccine escalates emory university researchers say that they've made some significant progress in the fight against covid-19 other researchers have created a new test to study hospitalized patients to find out just how quickly did they developed antibodies. >>to fight the infection. our teacher shawn tree has more on that. new research from emory shows that nearly all patients treated for covid-19 developed virus neutralizing antibodies those that bind the virus self to block infections antibodies are key to our understanding of what will be needed for protection against covid-19 researchers say there are more thn a 170 antibody tests against covid-19. >>and they all entered the virus target. >>normally stars kobe to the virus that causes covid-19 disease interacts with the receptor called ace too. we just found in the service of most cells within the long. >>and what is our producer spire body in massive quantities. and these antibodies can stick around for a long period of time off to the infection is your sauce, researchers focused on how antibodies resp

new studies out of emory showed that there are specific types of antibodies that formed in the bloodalized patients. these antibodies dubbed viral neutralizing antibodies. particularly target the part of the virus that is thought to be the key that allows the virus to enter a human cell. as we are learning more about how this virus operates, i don't think we know quite yet what exactly the presence means for immunity, for example, how much of the antibody actually needs to be present to potentially have an effect on killing the virus. but we're definitely making great progress. >> dr. ravi, the cdc quietly released new guidelines on reopening businesses and schools, including sneeze guards in restaurants, teachers and kids wearing masks in school. >> i'm definitely glad the guidelines were released, you know, and would have hoped they would have come out a little bit earlier, as many states and communities are already moving ahead above these guidelines. however, these guidelines do provide a good overall framework for a three-staged approach. it doesn't cover every scenario. i think

emory university researchers finding a specific virus-neutralizing antibody in patients within six days of testing positive for covid-19. >> not only shows that you've been exposed to the virus and have made antibodies against it, but those antibodies at least, you know, to the extent we've tested now, seem to correlate with blocking a viral infection. >> reporter: by finding that key antibody, scientists say it will help them create a better test and vaccine. one unknown, how long does protection last? >> i think going forward, it will be important to understand the durability of these immune responses over the next few months to years after infection. >> reporter: but tonight, questions about the reliability of some of the crucial antibody tests on the market. at its peak, there were 170 different ones, most without fda emergency use authorization. this rapid antibody test bought at a pharmacy uses just a drop of blood and works similar to a pregnancy test. the screen with results turning red. it didn't work. >> there's apparently no line at the front door. i first took a test on may

trial emory university.y. >> i think remdesivir is going >> i think remdesivir is going to be one importantl, but we also need to look for other ways ti help our patients. >> reporter: in the next phase of the trial, dr. mehta and colleagues are adding even more vid-19, combining remdesivir,st covid-19, combining remdesivir, multiplying, with a powerful multiplying, with a powerful anti-inflammatory drug, a so- called immune modulator that aims to prevent organ damage by calming down an inflamed immune system. remdesir stops the virus from replicating inside the cell, and the immune modulator puts out the fire. >> what the remdesivir does is stops the spark, and the immune modulator will hopefully be putting dirt on the fire to t mpen it out. >> reporter: a one-two punch. >> a one-two punch. >> reporter: dr. mehta's team is looking at whether this powerful combination that could make recovery even faster and possibly reduce the mortality rate in a way remdesivir itself has not been able to do. it's a strategy based on years of aids research. dr. anthony fauci. >> we were struggling with dru

force in brazil social media landscape a decade ago he was destined for life in the lib oratory with emory no quickly realized he could make more of an impact as a science communicator online thinks are part of what is in a short few years he built a massive following especially on you tube the stilling complicated scientific topics into comprehensive easy to digest videos and live streams. which are part of the work for top how quick or how and that was all before that 90 after the outbreak yammering no dedicated his work to informing brazilians about the virus what appears shock or not we're getting here to what would a poor quality decrease be used to punish his stature has soared as millions in the country have turned to his videos for answers answers that have been sorely lacking in the brazilian media mix which tends to focus more on the numbers less on the science behind them. but when you're taking on a president like share your goal so narrow the free market preview for everyone but if you need to be pretty confident about the facts which they know is that when you look out of my

maria sundaram is an epidemioloigst at emory university in atlanta, who specialises in vaccines. forjoining us on bbc news, it is great to talk to you. let's ask you the timeline we have heard from donald trump, how realistic is that? the timeline is extraordinarily optimistic. why? normally when we develop a vaccine, it usually takes at least ten years from the beginning of the development team being able to be given to people. we are talking about a vaccine and seven months, for people to receive, this is a timeline that is truly something that we never achieved before and it is extraordinarily optimistic. like he thinks he has given the timeline? i think the goal of the programme and obviously it is very important to have a vaccine as quickly as possible, it is one tool in the pandemic response toolkit and i believe and it is hard to say on any given day what the purpose of his state m e nts given day what the purpose of his statements might be but i believe it is meant to say when we would like to have that available. if we had success with a vaccine is it the silver bullet i

>> there are some new studies out of emory that showed that there are specific types of antibodies thatthe blood of hospitalized patients, and these antibodies dubbed viral neutralizing antibodies particularly target the part of the virus that is thought to be the key that allows the virus to enter a human cell. as we are learning more about how they operate, i don't think we know quite yet what exactly the present means for immunity but we're definitely making great progress. >> the cdc quietly released new guidelines on re-opening businesses and schools including sneeze guards in restaurants and teachers and kids wearing a mask in school. what do you think about these guidelines? does anything stick out to you? >> these guidelines do prood fra three-staged appto ma of our estions surrounding transit and hospitals. one part that did stand out to me was the expanded testing practices. there still exists a disconnect between wanting to test the broad population and the act to test and have those tests done in a timely manner. there were no specifics as to how that would be achieved. >> w

emory experienced an which incident close to home. the column was called "what is it" and explained his son james had been assigned to write an essay on free enterprise. that was a common topic in the post-world war ii years. i have read dozens of essays over the course of my research. following his dad's suggestion, james began seeking a definition. he perused the family encyclopedia to no avail and checked of the reference books including three dictionaries without finding anything. after satisfying himself his son had searched deciduously, they came up with the definition they came up with a definition that works well enough to earn james a grade of a on the assignment. finding a reference he found worrying. he sent his secretary to the public library knew that many of the thousands of reference forks would contain a definition -- works would contain a definition. three librarians unsuccessfully took up the challenge. for emery, the lack of readily available definition represented a crisis. for more than 150 years, freedom of enter

mclean: clearly you know more about the emory for world war ii than i do. what i would say is the more popular and well attended day is the day of partisans on april 25, which is a national holiday, and is celebrated all over italy. i think that certainly the , the late date is a clear sign of the mixed memory of it and the very ambivalent feelings italians have over world war ii. invasion ofthe yes, oneor abyssinia, of the major lines of argument hadthat ethiopia still slavery and therefore they were were,ians and therefore should be controlled by a better civilization. narrativehis is a that is furthered by the fact that ethiopia is a member of the league of nations, but only provisionally. the provision is that ethiopia is supposed to get rid of slavery. mussolini argues he has a right to invade because they don't. hecourse, once he invades, frees the slaves and then has them working for the fascists, so as not really freeing the slaves and it is actually much more like this postcard and others, where they have images downhill. people can you speak to th

but our own emory university hospital did some of those very trials, and we will rely on their experience, their expertise, to help us, even as we develop odd lines for how it is going to be used. so we would certainly not be recommending its use for anyone who was identified as potentially at risk. i want to also reflect on the fact i am not an elected official. answering as a passionate public health official. reporter: governor, the extended restrictions you announced on business that run until the end of the month, do you tend for any of those are all of those to expire at the end of the month? governor kemp: i wouldn't be able to answer that right now. we just implemented this. we are going to do like we did last time we had the order, continue to watch the numbers. it is important for people at home to realize, the folks tuning in, that the data is always a couple of weeks behind. we are just now being able to really dig into the data from the move i made a couple of weeks ago. you know, you have a good feeling avoid you think that data is, based on other things we are looking at be

even the lead investigator at m emory university says nothing is easy. >> it comes with its own challenges. >> reporter: dr. evan anderson says challenges for this type of vaccine includes that it's difficult to store, difficult to mass produce, and no one knows yet whether it's effective. moderna is testing the vaccine on humans without waiting for animal trials, a speed that was unheard of before the pandemic. the company is already preparing to produce its vaccine in mass quantities, on the sheer hope it gets approved and can be distributed almost immediately. >> the biggest source of pressure is the fact that, you know, this is personal. i think for my colleagues and i who are in the front line of trying to develop a vaccine, it's an equal weight of the sense of potential that we can do something about it and a tremendous sense of responsibility that we have to do something about it. >> reporter: and jim, just this morning, moderna announced it is partnering with the pharmaceutical company to mass-produce this vaccine if, in fact, it gets approval. the company says phase 2, phase 3 are

in february, emory university neuroscientist was conducting research for the national institutes of healthyet allegedly failed to disclose he was being paid by the chinese. in january, the head of the chemistry department at harvard, charles lieber accused of taking $1.5 million from china to set up a research lab in wuhan. finally, last year, a professor from ucla was convicted of selling u.s. missile secrets to china. now is facing two centuries in prison. >> tucker: that's a long time. trace gallagher, thank you so much for that. michael flynn saw china as america's top international threat. he said that out loud, so the obama administration framed him as a russian spy and destroyed his life and his family. in now, we have a newly revealed information about how and why they did that and the attitudes that drove him to crush plan and derail the first term of president trump. that's next. staying connected your way is easier than ever. you're just a tap away from personalized support on xfinity.com. get faster internet speeds with a click. order xfi pods to your home in a snap. or change

. >> in particular, "the birmingham world," a black newspaper and its editor emory jackson. he writes about long before anyone else that dr. king is invoking gandhian principles. he becomes referred to in the black press as the black moses. the white editors, they were just living in a different world. >> the majority press, the white press basically ignored african-americans and not just episodes of violence against them, but achievements, anything to do with their daily life. basically flat out ignored them. >> they didn't even often use the names of black people because that would be a sign of respect. it's galling now to look at the level of disregard and oblivion that was in the media at that time. >> so long as you sit in the back, you have a false sense of, inferiority, and so long as you let the white man sit in the front and push you back there, he has a false sense of superiority. >> montgomery bus boycott. unbelievably successful from the very first day, and it took weeks to get a national reporter in there. i think it was six weeks before a news magazine came in

. >> reporter: this, as a new study out of emory university, finds antibodies could mean some level of emory scientists discovering a specific virus neutralizing antibody in hospitalized covid patients within six days of testing positive. >> what our test does is not only shows that you've been exposed to the virus and have made antibodies against it, but those antibodies at least, you know, to the extent we've tested now, seem to correlate with blocking of viral infection. >> reporter: researchers say there are still unknowns. >> so at this point we don't know how long people would be immune. >> i think going forward it'll be important to understand the durability of these immune responses over the next few >> rep a as far ashosa he decid those rapid tests in their own clinics because of quality issues. robin? >> all right, eva, thank you. >>> now all 50 states, as we know, taking steps towards re-opening. while new cases, hospitalizations and deaths are falling in most places, there are still hot spots appearing across the country and steve osunsami joins us from outside the cdc in a

doctor from emory university, doctor, thank you for your time.of people are looking for this. have we put too much hope in this treatment, dr.? what you think so far? >> well, thank you. we do know though we have data that is promising. but it is showing that we are able to get persons of covid-19 home to their families a little bit earlier than the wonderful state of care that we are giving them in the hospital. but we need to look at the bigger data set to see what the impact really will be. and importantly, which patients it will help the most. >> bill: what i understand is that it will slow down the growth of the cells. that's what helps the patient recover. what have you learned about th this? >> one a virus enters the body, it attacks our cells and uses the cell's own machinery to make more of itself. this medicine works by stopping that process so that the virus cannot make more of itself. it allows the immune system and the rest of the body to catch up to help kill the virus and get it out of the body. >> bill: okay. are you optimistic? i

next, we go to emory kelly from florida state. >> hello, folks. thank you for doing this. i was just wondering with this being the first time humans have had a chance to experience flying on a falcon nine and a crew dragon after all these years of them flying, have you gotten any input from bob and doug? is it a smooth ride? what was it like? >> i have not heard specifically on how it flies. i do know that we are going to hear from them soon. i don't know at what point that will take place. i don't know if you have that specific information. it was a very smooth ride. you can see from the webcast that it looks quite smooth. a friend of mine that is a filmmaker says you need to put some shake into the camera to make it look more realistic. our next question will be from paul brinkman from upi. -- iwould like to ask elon realize the mission is not over but it is a significant achievement at this point. what is the impact of success for this program on spacex as a whole including the development of starship? it is a tremendous accomplishment for spacex in partnership with nas

carlos del rio the executive associate dean of emory university school of medicine at grady health system, and sir, i mean, you may have heard some of nick watt's report there. cdc officials have told our drew griffin, quote, we are working under a black cloud of an administration that doesn't have our backs. we've been muzzled is what one said. what's your reaction to hearing that? >> well, it's very concerning because cdc is one of our national treasures, and having cdc in the past lead the response to many, many problems that i can remember from hiv to legionnaire's disease. zika in the forefront. h1n1. dr. rich bessert literally on the news on a daily basis during the outbreaks. so i think the cdc has always shown leadership and has always done a remarkable job. they have great scientific expertise. they have the right people. the right tools, the right laboratories. so i have been really dismayed and quite frankly disappointed by not seeing cdc at all in part of this response and you almost wonder, as you play chess, somehow gave up your queen and think you'll be able to win. >> that

we're honored that the nih gave my colleagues at the emory vaccine center availability to do early testing on these vaccines and throughout the summer we'll work hard to evaluate these vaccines. as dr. fauci mentioned, ideally, if everything goes well, we should have a vaccine ready forwa towards the iend of the year or early spring. so we're looking forward to these trials rolling out and being able to offer a true preventative vaccine for many people. >> thanks for being with us. >> thank you very much. >>> at any moment we'll hear from new york governor andrew cuomo. he's giving an update on the coronavirus outbreak in new york. we'll bring it to you live when it happens, there's a picture of the podium as we wait for him to take it. >> this in from puerto rico, still recovering from hurricane maria and lockdown by the coronavirus, has just been hit by another earthquake. you see the pictures coming in from puerto rico. officials are now just starting to assess the damage. we'll get you more when we get it. [anthony] hey mama, what's up? [mama] i'm confused. confused about what, everyth

carlos del rio, dean from emory university of school of medicine and grady health center. and you're aware americans are confused about whether to go back out into the world. is it healthy for them to do so if it is not fully healthy how do they mitigate the risk? is it worth the risk? what do you say to them? >> well, i say to them is that this epidemic is not over. this virus is still here. it is infectious. the cases as you heard previously are going up. and i think simply because you haven't heard about it and you are getting the messages to go back, it is not safe to go back. and i would say continue to take care of yourself, practice social distancing and staying home and not going to crowded places and wearing a mask and washing your hands frequently. >> what do you say to people, including a salon owner there, who was arrested, saying, look, without this business, kids are going hungry. how do you -- how do you balance that if you have food insecureoit to the point it is affecting the children not just the adults in the family. >> it is incredibly hard and i feel f

evilen the lead investigator at emory university says nothing is certain. >> if it's successful t could allow us to shorten the timeline for developing new vaccines in the future. but it comes with its own challenges. >> reporter: he says challenges for this type of vaccine include that it's difficult to store, difficult to mass produces and no one knows whether it's effective. they're testing maderna's vaccine on humans without waiting for animal trials, a speed unheard of before the pandemic. they're already preparing to produce their vaccine in quantities on the sheer hope it can be distributed almost immediately. >> the biggest source of pressure is the fact that this is personal. i think for my colleague and i in the frontline of trying to develop a vaccine, it's an equal weight of the sense of potential that we can do something about it and a tremendous sense of responsibility tha responsibility that we have to do something about it. >> reporter: as maderna seeks to move to phase two and three of trials, it's partnerring to ramp up manufacturing. if this does get some sort of appr

carlos del rio, a professor at emory university, and bob kosta, moderator of "washington week" on pbs. dr. benjamin, the a.p. has an exclusive this morning. we all want to reopen. this guidance says there needs to be a coordinated national response, right? calculated risk management, that is the opposite of what president trump has done. what is your reaction to that? >> we have to have a coordinated plan. we need to free the cdc to do what they do best. they're very good at given guidance. when i was a state and local health officer, i used their guidance each and every day. it's important to see the light of day, and we need to see it right away. >> bob, we all want to reopen. why are our current options lie about the risk and open everything up? tell the truth about the risk and stay closed? why wouldn't the white house want to use this guidance from the cdc and open responsibly regionally? >> the interesting story to me as a reporter, stephanie, is the white house isn't actually driving the conversation. i've talked to governor after governor in both parties. they are the ones mak

but we need to keep those emories alive. >> there's a lot of things to be learned and we continue to study t 1918 flu. the important lesson is that pandemics can be very serious. but also, pandemics can be widespread an not that serious. there's a degradation of pandemics. you always must prepare for the worst-case scenario, even though you might have a mild pandemic like a one such as in 1968, or an intermediate pandemic that happened in 1957. >> t the current pandemic is les severe than the planning zeroes had had. it could bece less severe and doesn't affect a lot of people. it could become more severe it could mutate to a deadly or virus. it could go along the same way. only time will tell, we have to be ready to o pivot every spawn differently ifhe virus changes. >> yeah one thing you can predict about it is that it is unpredictable. >> we still know much less than we would like about influenza, t the experiences of the individuals who endured the pandemic of 1918, continue to contribute to our understanding of the disease. >> we are infinity better than we were prepared 100 yea

ben lopman, an epidemiologist at the rollins school of public health at emory university, says the livel markets here pose their own significant health threat. >> anywhere that humans come into contact with animals is a potential exposure, is a potential opportunity for an infection to jump from animals to humans. the live markets, they might pose a special rick because of the diversity of animals that are sold. >> reporter: according to the cdc, more than six out of every ten known infectious diseases in people can be spread from animals. the leader of the world health organization -- >> a source of affordable foot and livelihood for millions of people all over the world. in many places, there have been poorly regulated and poorly maintained. >> reporter: video obtained by cbs news from animal rights activists of live animal markets coast to coast show unsanitary conditions. animals in cages stacked on top of each other with feces, urine, or blood able to flow between cages. >> in terms of how sanitary these markets are, do these markets pose any kind of health threat. >> i wouldn't ea

colleen craft at emory university hospital in atlanta. what is your reaction, doctor, to this huge new study on hydroxychloroquine? >> i think we just a little need to go back to what we know, which is using scientific evidence and objectivity anytime we're recommending a therapeutic. i don't know why the pandemic and we feel like during this pandemic that we need to go outside of those bounds. just to give optimism, like you were just talking about. but it is really important that we follow all these things we always have been doing. our first desire as clinicians and physicians and healthcare workers is to do no harm. and so i think that we want to focus on that in our results and in our practices. >> so the data here focuses on a particular effect of this, causing irregular heart beat known as an arrhythmia that can lead to sudden cardiac death. i wonder, the white house doctor gave this medicine to the president who we know, dr. sanjay gupta said this on our air, has signs of heart disease, plaque, in his blood vessels here. a risk to

let's bring in carlos del rio at emory university medical school in atlanta. you're in that state.en you look at these numbers, and then add on to it, dr. del rio, the new model that projects nearly 5,000 deaths in your state, in the state of georgia, by august 4th, that's less than three months from today, how should governors and mayors think about these numbers as they're making their decisions? >> i'm very, very concerned. and i'm very concerned because the infection rate will continue to go up and the death rate will continue to go up. and obviously governors are making decisions based on wanting to restart the economy, but it is going to be really hard to think about truly restarting the economy in a situation like that. i think it is incredibly tricky. how do you ensure you provide safety and decrease the risk of infection and still have the economy going. this was said this morning, when -- in the clip just a little while ago, you know, you have mass transit, many, many businesses in which you simply cannot practice safe distancing, which you simply have proximity to other

james koran is dean of public health at emory university and former assistant surgeon general at thecdc. >> has the cdc been sidelined here? >> i think the perception is that the cdc has been sidelined and at least part of the time. once you feel like the work you're doing is going through a political lens, it gets to be very, very discouraging. >> reporter: on march 2nd as covid-19 was racing across the globe a cdc internal daily report obtained by cnn found evidence of local transmission in 29 other countries. two days later, that had grown to 85 international locations. the next day, march 5th, three of the top six countries affected by the disease are in europe. internal e-mails reveal a cdc global travel alert is about to be issued. expected to be posted that night. it would have urged precautions for international travel anywhere almost two months after a travel warning had been issued for china. but it was delayed for unexplained reasons. the travel alert that was supposed to be posted march 5th does not take place until march 11th the same day president trump would announce h

a new study from emory university finds that quote, disproportionately black counties account for 22%all u.s. counties but have been home to 52% of coronavirus cases and 58% of deaths from covid-19. that same study finds that 91% of those majority black counties are many states have started to reopen. it's great to talk to you again. it's been an mri. however you want to this inequality. it's staring us in the face. considering what we're looking at economically and from a health result stand point, give us your advice of how do we design or recover looking forward that it eliminates -- >> we have to start looking at what the systemic issue but plaguing in these parts. the task force that stood up. she has a sub committee that i'm co-chairing on equity and vulnerable populations. i think we have to bring that focus to the group. some of the things we must do to make sure the relief in the cares act really speaks to the short term and long term solutions in these areas. i think some has been sent out. we have to be realistic about these people continue to go to work throughout the pand

didn't do it they might have perford it a so other sho anyway, this is a big deal maroon 5 is peorming emories le good music, anotr bandi i enjoy is actually a guy, brendan yuri from panic!t the disco. heas awesome he's got pipes lo that guy. he came on set with the roots. don't you rememberhat one? we sang 30 songs hit them out of the park i called him up, i said, hey you're a friend of the show. would you ever want to do something with me? i know i'm not a singer but let's do a fun bit or something with the rootses and he said yes, because he's the constitute els soere is me, brendan yuri, and the roots performing "under pressure" by david bowie and freddie mercury. ♪ ♪ ♪ pressure pushing down on me pressing down on you no man asks for ♪ ♪ under pressure that burns a building down splits a family in two put people on streets ♪ ♪ ♪ it's the terror of knowing what this world is about ♪ ♪ watching some good friends screaming let me out ♪ ♪ may tomorrow get me higher ♪ pressure on people people on streets ♪ ♪ ♪ can we give ourselves one mor chance ♪ ♪ why can't we give it that one more chance ♪

even the lead investigator from moderna's vaccine trial from emory university says nothing is successfulsful it could allow to us shorten the timeline to developing new vaccines in the future. but it comes with its own challenge. >> reporter: dr. evan anderson saidle chas for this vaccine include that it's difficult to store and mass produce and no one knows whether it's effective. the nih is testin the vaccine on humans without waiting for animal trials, a speed unheard of before the pandemic. the company is already preparing to produce its vaccine in mass quantities on the sheer hope it gets approved and can be distributed almost immediately. >> the biggest source of pressure is the fact that, you know, this is personal. i think for my colleagues and i who are in the front line of trying to develop the vaccine, it's an equal weight of the sense of potential that we can do something about it at a tremendous sense of responsibility that we have to do something about it. >> reporter: moderna says right now, it's on track to move into phase two/phase three trials and with what. we'll be ab

even the lead investigator for the trial at emory university says nothing is certain. >> if it's successful, it could allow us to shorten the timeline for developing new vaccines in the future. but it comes with its own challenges. >> reporter: dr. evan anderson says challenges for this type of vaccine include that it's difficult to store, difficult to mass produce, and no one knows yet whether it's effective. the nih is testing moderna's vaccine on humans without waiting for animal trials, a speed that was unheard of before the pandemic. the company is already preparing to produce its vaccine in mass quantities on the sheer hope it gets approved and can be distributed almost immediately. >> the biggest source of pressure is the fact that, you know, this is personal. i think for my colleagues and i who are in the front line of trying to develop the vaccine, it's an equal weight of the sense of potential that we can do something about it and a tremendous sense of responsibility that we have to do something about it. >> reporter: ana, as moderna seeks to move towards phase two and phase three

. >> reporter: emory university health and epidemiology professor carlos del rio says the impact of thenor's shelter in place order clearly increased the number of infects and deaths. >> it is about providing people jobs, it is about providing people opportunity, it is about health, so unemployment is -- it causes disease. unemployment causes poverty. we have to find a balance. but we need to do it carefully. we need to be careful in the to be irresponsible. >> reporter: dr. del rio said it was unsettling it see the large crowds we saw over memorial day weekend, but the real test will come in a couple of weeks to see if this approach of social easing will lead it a faster rate of the virus spreading here in georgia. >> pretty flat for a long time, not going up or down. it has been interesting to watch. nick valencia doing terrific reporting for us in georgia. thanks so much. >>> so face shield versus face mask. what is the difference? dr. sanjay gupta back to answer your questions next. >>> okay, you have more questions about coronavirus and dr. sanjay gupta is back to answer them. sanj

country and organizing, the administrative center, northwestern, johns hopkins, umass, georgia tech and emory, this is important that has been developing point of care technologies for years. typically the cycle of the process from idea of the technology to getting it widely disseminated is five to six years. we have turbo charged the network with a lot more experts and thought deeply about how to pivot for covid-19 and put into place a process, we call them innovation funnel, and the shark tank is part of it, to try to accelerate this by more than tenfold. we would like to get ideas into the network, have them reviewed by multiple panels, create milestones, have these very intense review experiences, and then have successful technologies emerge with manufacturing and distribution, within five, six months. >> and so i want to use a graphic from nih, i call it the light bulb graphic. you have it on the leth side of the screen. a lot of light bulbs. a lot of people come to the table and say we have ideas. as you move across the graphic, hopefully we can show it, it gets viewer and fewer, and th

. >>> new video and photographs have emerged in the killing of ahmaud emory. >> there's a new look from the side of the shooting. >> reporter: new video in the case of ahmaud arbery. it is reviewing this sur stray lens vid surveillance video, showing a person walking up to a house and then leaving. that man, they believe, was arbery. this evidence was consistent with the evidence known to us. know iing the house was empty, under construction. and that video was reviewed before the mcmichaels were arrested. arbery's death sparked nationwide protest. the 25-year-old, seen running, his family says, unarmed. the mcmichaels spursuing arbery because they thought he was a burglary suspect. arbery's mother has not watched that video made public. what was your reaction when you heard the mcmichaels had been arrested. >> actually, i was in a numb state because i had waited for too months. two months and two weeks. >> reporter: william ryan recorded the video of the shooting. his attorney, kevin goff. was he with the mcmichaels? >> he was trying to get a picture. >> reporter: why? >> there had bee